Navigation Links
Testimony to Congress Denounces FDA Reliance on Self-Policing
Date:2/26/2008

TARPON SPRINGS, Fla., Feb. 26 /PRNewswire-USNewswire/ -- John Williams, a shrimp fisherman and executive director of the Southern Shrimp Alliance, testified today before the House Subcommittee on Oversight and Investigations of the Commerce and Energy Committee regarding import seafood safety. Williams criticized the Food and Drug Administration's (FDA) reliance on importers to verify food safety and recommended Congress take legislative actions.

"On behalf of the U.S. shrimp industry, I would like to thank Representative Charles Melancon for inviting us to share our experiences with Congress," said Williams. "We appreciate his continued support for equal application of food safety requirements on imported and domestic seafood."

"The FDA has failed to enforce food safety laws on imported seafood. The FDA's approach to imported food safety is to accept unverified representations from importers with only token inspections," explained Williams.

Concerns about the FDA's inability to assure the safety of imported seafood have caused at least eight states to conduct their own testing programs. Repeatedly, these states have found banned substances in the imports they test-seafood allowed by the FDA and the private sector to enter the U.S. market.

Since 2002, the state of Louisiana has had an Emergency Rule in place to test imported shrimp and crawfish for chloramphenicol. It added testing for fluoroquinolones in Chinese and Vietnamese seafood in 2007.

The impact of FDA's failures

The FDA's failure to prevent the importation of contaminated shrimp has a number of negative effects on the U.S. market, the U.S. shrimp industry and U.S. consumers that benefit from a diet of healthful seafood. First and foremost, farmed-shrimp imports contaminated with banned antibiotics, pesticides and other dangerous contaminants put the health of U.S. consumers at serious risk according to sound medical science that is recognized and applied worldwide.

Second, U.S. consumers are quite often unable to distinguish between safe and unsafe shrimp in retail markets and restaurants. Their fear of buying or being served contaminated imported shrimp depresses the overall consumption and demand for all shrimp, including healthful, wild-caught shrimp produced in the United States.

Finally, the FDA's lax inspection system allows volumes of low-value contaminated shrimp into the U.S. market. These illegal shipments depress the price for U.S. shrimp fishermen.

SSA is an alliance of the U.S. wild-caught shrimp fishery from eight states: North Carolina, South Carolina, Georgia, Florida, Alabama, Mississippi, Louisiana and Texas. For more information, please visit http://www.shrimpalliance.com.

Contact:

Deborah Long

Deborah@CohesiveCommunications.com

785.539.5218


'/>"/>
SOURCE Southern Shrimp Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NCPA President Steve Girouxs Testimony at FDA Behind the Counter Hearing
2. Governors Health Plan Hides the True Cost of a Mandatory Purchase Requirement, Testimony Shows
3. SHRM Testimony Urges Congress to Fix FMLA
4. Implementers, Advocates, Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology
5. Governor Rendell Tells Congress Prescription for Pennsylvania Will Improve Health Care Climate for Small Businesses
6. Statement by Robert D. Foreman, President of The Kidney Care Council, Regarding the HHS Report to Congress A Design for a Bundled End Stage Renal Disease Prospective Payment System
7. Congressman Buchanan Tours Florida Clinical Laboratory; Learns Vital Role in Patient Care
8. Congressman Altmire Tours Womens Health Clinical Laboratory; Learns Vital Role in Patient Care
9. Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting
10. Congresswoman Sutton Leads National Effort to Place Life-Saving AEDs in Americas Schools
11. Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... 05, 2016 , ... Health and wellness is a topic that should concern ... they are experiencing an illness. Migraines are a severe form of a headache and ... would not wish the pain on their worst enemy, the feeling can last for ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... Care for Patients with Rare Diseases, a continuing medical education (CME) event presented ... the first of its kind—and a first for ACCORD, whose mission is to ...
(Date:2/5/2016)... ... February 05, 2016 , ... KICVentures ( http://www.kicventures.com ) ... event in New York City on Thursday, January 21, 2016. Kingsley R. ... (both alumnus of the varsity Columbia soccer program) spoke at the event, offering ...
(Date:2/5/2016)... ... 05, 2016 , ... Susan Polk Health Insurance Company recently released ... to see in 2016. To view the report, see below, or visit Susan ... San Luis Obispo seniors who rely on Medicare health insurance and whose monthly income ...
(Date:2/4/2016)... CA (PRWEB) , ... February 04, 2016 , ... ... the "It's All About YOU Re-Treat" on February 19-21, 2016, in Southern ... is at Rancho Palos Verdes, California. These 30 professional speakers, including Clinical Psychologist ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... LONDON , Feb. 4, 2016 Summary ... most common cancer and the most common cancer in ... making the disease exceedingly prevalent. The number of women ... few decades, but the number of deaths has declined ... Breast cancer treatment has been revolutionized in the past ...
(Date:2/4/2016)... Mettler-Toledo International Inc. (NYSE: MTD ) today announced ... highlights: , Sales in local currency increased ... Reported sales decreased 3% as currency reduced sales growth ... per diluted share as reported (EPS) were $4.44, compared ... was $4.65, an increase of 10% over the prior-year ...
(Date:2/4/2016)...  Blueprint Medicines Corporation (NASDAQ: BPMC ), ... investigational kinase medicines for patients with genomically defined ... of directors of Lonnel Coats , a ... industry-related experience. Jeffrey Albers , ... strategic experience developing and commercializing numerous oncology products ...
Breaking Medicine Technology: